Form 8-K - Current report:
SEC Accession No. 0001640334-22-001896
Filing Date
2022-08-25
Accepted
2022-08-25 09:00:27
Documents
14
Period of Report
2022-08-24
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K artl_8k.htm   iXBRL 8-K 23093
  Complete submission text file 0001640334-22-001896.txt   147911

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA artl-20220824.xsd EX-101.SCH 5735
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE artl-20220824_lab.xml EX-101.LAB 15188
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE artl-20220824_cal.xml EX-101.CAL 908
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE artl-20220824_pre.xml EX-101.PRE 9638
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE artl-20220824_def.xml EX-101.DEF 2109
8 EXTRACTED XBRL INSTANCE DOCUMENT artl_8k_htm.xml XML 3709
Mailing Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 858-925-7049
ARTELO BIOSCIENCES, INC. (Filer) CIK: 0001621221 (see all company filings)

EIN.: 331220924 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38951 | Film No.: 221193418
SIC: 2834 Pharmaceutical Preparations